ES2013408A6 - Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento. - Google Patents

Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento.

Info

Publication number
ES2013408A6
ES2013408A6 ES8901049A ES8901049A ES2013408A6 ES 2013408 A6 ES2013408 A6 ES 2013408A6 ES 8901049 A ES8901049 A ES 8901049A ES 8901049 A ES8901049 A ES 8901049A ES 2013408 A6 ES2013408 A6 ES 2013408A6
Authority
ES
Spain
Prior art keywords
transcription
dna sequence
biotechnology
polypeptides
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8901049A
Other languages
English (en)
Spanish (es)
Inventor
Joseph P Brown
Daniel R Twardzik
Hans Marquardt
Goerge J Todaro
A Gregory Bruce
Timothy M Rose
Anthony F Purchio
Shiu-Lok Hu
Wen Chang
Suo Win Liu
Thomas J Franceschini
Mohammed Shoyab
Greg Plowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of ES2013408A6 publication Critical patent/ES2013408A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
ES8901049A 1988-03-24 1989-03-22 Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento. Expired - Lifetime ES2013408A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17265388A 1988-03-24 1988-03-24

Publications (1)

Publication Number Publication Date
ES2013408A6 true ES2013408A6 (es) 1990-05-01

Family

ID=22628611

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8901049A Expired - Lifetime ES2013408A6 (es) 1988-03-24 1989-03-22 Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento.

Country Status (22)

Country Link
JP (1) JPH0279981A (enExample)
KR (1) KR890014743A (enExample)
AU (2) AU3169589A (enExample)
BE (1) BE1004202A5 (enExample)
CH (1) CH681081A5 (enExample)
DE (1) DE3910084A1 (enExample)
DK (1) DK146789A (enExample)
ES (1) ES2013408A6 (enExample)
FI (1) FI891308A7 (enExample)
FR (1) FR2632321A1 (enExample)
GB (1) GB2219799B (enExample)
GR (1) GR1000876B (enExample)
HU (1) HUT50501A (enExample)
IE (1) IE890950L (enExample)
IL (1) IL89673A0 (enExample)
IT (1) IT1234961B (enExample)
LU (1) LU87489A1 (enExample)
NL (1) NL8900724A (enExample)
NO (1) NO891273D0 (enExample)
NZ (1) NZ228427A (enExample)
PT (1) PT90118B (enExample)
SE (1) SE8901031L (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
CA2037440A1 (en) * 1990-03-02 1991-09-03 Gregory D. Plowman Her3: a novel egf receptor homolog
EP0739984A1 (en) * 1995-04-26 1996-10-30 San Tumorforschungs-Gmbh Bivalent polypeptides containing at least two domains
US6852506B1 (en) 1996-04-10 2005-02-08 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein
CA2249213A1 (en) * 1996-04-10 1997-10-16 Human Genome Sciences, Inc. Extracellular/epidermal growth factor-like protein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0108132A1 (en) * 1982-05-06 1984-05-16 Applied Molecular Genetics Inc. The manufacture and expression of genes for urogastrone and polypeptide analogs thereof
JPS6028994A (ja) * 1983-07-08 1985-02-14 Wakunaga Seiyaku Kk 〔２１―ロイシン〕ヒトウロガストロン
WO1985002198A1 (en) * 1983-11-01 1985-05-23 Amgen Microbial expression of type i transforming growth factor, polypeptide analogs thereof and hybrid egf/tgf polypeptides
JP2554459B2 (ja) * 1984-07-02 1996-11-13 アース製薬 株式会社 β−ウロガストロン遺伝子、対応プラスミド組換体及び対応形質転換体
FI862734A7 (fi) * 1984-10-30 1986-06-26 Oncogen Uudet polypeptidit, joilla on kasvutekijäaktiivisuutta ja nukleiinihap posekvenssit, jotka koodaavat polypeptidejä.
GB8507666D0 (en) * 1985-03-25 1985-05-01 Wellcome Found Epidermal growth factor production
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
GB2210618B (en) * 1987-10-08 1991-10-16 British Bio Technology Synthetic egf gene
ES2081801T3 (es) * 1987-10-30 1996-03-16 Bristol Myers Squibb Co Plasmidos de expresion.
EP0372005A4 (en) * 1987-10-30 1990-06-26 Oncogen EXPRESSION SYSTEMS FOR THE PREPARATION OF POLYPEPTIDES IN PROKARYOTIC CELLS.

Also Published As

Publication number Publication date
IL89673A0 (en) 1989-09-28
PT90118B (pt) 1994-07-29
AU2990492A (en) 1993-03-04
AU3169589A (en) 1989-09-28
FI891308A0 (fi) 1989-03-20
LU87489A1 (fr) 1989-10-26
PT90118A (pt) 1989-11-10
KR890014743A (ko) 1989-10-25
SE8901031D0 (sv) 1989-03-22
SE8901031L (sv) 1989-09-25
FI891308L (fi) 1989-09-25
GB8906758D0 (en) 1989-05-10
IT1234961B (it) 1992-06-09
CH681081A5 (enExample) 1993-01-15
GR1000876B (el) 1993-03-16
IE890950L (en) 1989-09-24
BE1004202A5 (fr) 1992-10-13
NO891273D0 (no) 1989-03-22
GR890100185A (en) 1990-01-19
DK146789D0 (da) 1989-03-22
NZ228427A (en) 1993-03-26
FR2632321A1 (fr) 1989-12-08
HUT50501A (en) 1990-02-28
GB2219799B (en) 1992-10-14
DK146789A (da) 1989-09-25
FI891308A7 (fi) 1989-09-25
JPH0279981A (ja) 1990-03-20
GB2219799A (en) 1989-12-20
NL8900724A (nl) 1989-10-16
IT8919917A0 (it) 1989-03-24
DE3910084A1 (de) 1989-11-16

Similar Documents

Publication Publication Date Title
Kurtz et al. Renal mesangial cell cultures as a model for study of erythropoietin production.
DE69420726D1 (de) Embryonische stammzelle zur herstellung von chimäre und transgen-ongulaten
ATE286126T1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
ATE186840T1 (de) Zusammensetzungen und methoden zur wundbehandlung
ATE107958T1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
KR970704481A (ko) 생인공성 외세포성 매트릭스용 조성물 및 방법(compositions and methods for a bioartificial extracellular matrix)
ES2054676T3 (es) Regulacion de transcripcion especifica de semillas.
ES2127221T3 (es) Utilizacion de colageno reticulado para la fabricacion de una membrana suturable, biocompatible de resorcion lenta.
BR0316468A (pt) Composição para reparar tecido orgânico e métodos para preparar tecido orgânico, uma imperfeição de tecido orgânico e um ferimento de queimadura em um paciente e para produzir uma composição para preparar tecido orgânico
NO941703L (no) Fremstiling og anvendelse av multimere hemoglobiner
ATE399203T1 (de) Varianten des wachstumsfaktors der vaskulären endothelzellen, ihre verwendung sowie methoden für ihre herstellung
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
ATE2772T1 (de) Neue emulgatoren, diese emulgatoren enthaltende waessrige isocyanat-emulsionen sowie deren verwendung als bindemittel zur herstellung von formkoerpern.
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
DE50004951D1 (de) Verfahren zur Herstellung von stabilem Alginatmaterial
ES2150275T3 (es) Utilizacion de un extracto de algas como agente antibacteriano y/o antifungico, y compuesto que comprende dicho extracto.
ES2013408A6 (es) Un metodo para preparar por biotecnologia polipeptidos que tienen actividad de factor de crecimiento.
ATE246935T1 (de) Zns neuroregenerative zusammensetzungen und deren verwendungen
ES2025743T3 (es) Procedimiento para preparar polimeros con contenido de grupos tiol.
ES8405842A1 (es) Procedimiento de producir razas estables de celulas de mamiferos
ES2032439T3 (es) Procedimiento para preparar derivados de triazoliletanol como reguladores del crecimiento de las plantas. (reserva del art. 167.2 cpe).
ATE46181T1 (de) Derivat von keratin, verfahren zu dessen herstellung und dieses enthaltende behandlungszusammensetzung.
DK475979A (da) Antibiotikum fremgangsmaade til dets fremstilling og dets anvendelse som laegemiddel
ATE452643T1 (de) Herstellung eines biologischen faktors und schaffung einer immunologisch vorteilhaften umgebung unter verwendung genetisch veränderter sertolizellen
EP0195087A4 (en) Cyclic double-stranded dna, process for its preparation, microorganism containing said cyclic double-stranded dna, and process for preparing protein containing antigen determinant site of poliovirus capside protein vp1 using the same.